BSECompany Update13 Aug 2026 · 13 Aug 2026, 04:44 pm
Newspaper Publication of Unaudited Financial Results for the quarter ended June 30, 2026.
Kwality Pharmaceuticals Ltd · 539997
✦ AI SummaryResults
Kwality Pharmaceuticals Ltd has published unaudited financial results for the quarter ended June 30, 2026, as per the requirement of Regulation 47 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Kwality Pharmaceuticals Ltd - 539997 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Attachments (1)
📄pdf
Download →
bcccea07-6089-461d-bae5-d54eeb8a2708.pdf
View document text
To Date: August 13, 2026
The Department of Corporate Services,
BSE Limited
Phiroze Jeejeebhoy Towers,
Dalal Street,
Mumbai- 400001
Ref: Scrip Code: 539997
Subject: Newspaper Publication of Unaudited Financial Results for Quarter
Ended JUNE 30, 2026
Dear Sir/Madam,
As per the requirement of Regulation 47 of Securities and Exchange Board of India
(Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed
herewith is the copy of the Newspaper Publication of Unaudited Financial Results
(Standalone and Consolidated) for the quarter ended June 30, 2026 published in the
newspaper viz. Financial Express (English) and Punjabi Jagran (Punjabi) on 12th
August, 2026.
Kindly take the above on your records.
Thanking You
Yours Faithfully
For Kwality Pharmaceuticals Limited
Ramesh Kumar
Managing Director
DIN: 00462656
Financial Express dated August 12, 2026
Punjabi Jagran dated August 12, 2026